Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Shirwan, Haval	University Of Missouri-Columbia United States	Developing a novel agonist of CD137 for cancer immunoprevention	5UG3CA290305-02	Altaf Mohammed, Ph.D.
Shu, Xiao-Ou	Vanderbilt University Medical Center United States	Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer	5R01CA227133-05	Matthew Young, Ph.D.
Shureiqi, Imad	University Of Michigan At Ann Arbor United States	ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism	5R01CA266223-04	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Siddique, Shahzad	Commonspirit Health Research Institute United States	CIRI Oncology Research Alliance	3UG1CA189809-11S1	Vanessa A. White, M.P.H.
Sidransky, David	Johns Hopkins University United States	Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma	5R01CA265975-04	Wendy Wang, Ph.D., M.Sc.
Sieren, Jessica C	University Of Iowa United States	Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers	5R01CA267820-03	Nicholas Hodges, Ph.D.
Sigel, Keith Magnus	Icahn School Of Medicine At Mount Sinai United States	The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors	4R01CA256660-05	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Simeone, Diane M	University Of California, San Diego United States	Biomarker Validation in Pancreatic Cystic Neoplasms	5U01CA282272-03	Matthew Young, Ph.D.
Siminski, Suzanne M.	Frontier Sci & Technology Rsch Fdn, Inc United States	CASCADE Coordinating Center	5U24CA275417-04	Maria Silvina Frech, Ph.D., M.S.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis	5R01CA222900-06
Singal, Amit	Ut Southwestern Medical Center United States	Clinical Validation Center for Hepatocellular Carcinoma	5U01CA271887-04	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States	5U01CA230694-05
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules	4U01CA283935-03	Sidney Fu, M.D.
Siskind, Leah J	University Of Louisville United States	Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease	1R01CA305985-01	Marjorie Perloff, M.D.
Skates, Steven J	Massachusetts General Hospital United States	Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer	5U2CCA271871-03	Christos Patriotis, Ph.D., M.Sc.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants